Adaptin Bio (APTN) Accumulated Expenses (2024 - 2026)

Adaptin Bio's Accumulated Expenses history runs 3 years deep, the most recent figure standing at $272381.0 for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 59.84% year-over-year to $272381.0; the TTM figure through Mar 2026 stood at $272381.0 (down 59.84% YoY), while the FY2025 annual figure was $596465.0, down 38.39% from the prior year.
• Accumulated Expenses came in at $272381.0 for Q1 2026 at Adaptin Bio, down from $596465.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $968130.0 in Q4 2024 to a low of $272381.0 in Q1 2026.
• A 3-year average of $577902.7 and a median of $559060.5 in 2025 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses slumped 38.39% in 2025 and slumped 59.84% in 2026, its largest moves.
• Adaptin Bio's Accumulated Expenses stood at $968130.0 in 2024, then plunged by 38.39% to $596465.0 in 2025, then slumped by 54.33% to $272381.0 in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $272381.0, $596465.0, and $430506.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison